Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30050713HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050714HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050715HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050716HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20001223HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20054272HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20026602HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44004968HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44011985HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44011854HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TCGA Plot Options
Drug Information
GeneTACR1
DrugBank IDDB11949
Drug NameVestipitant
Target IDBE0000384
UniProt IDP25103
Regulation Type
PubMed IDs21229983
CitationsDi Fabio R, Alvaro G, Griffante C, Pizzi DA, Donati D, Mattioli M, Cimarosti Z, Guercio G, Marchioro C, Provera S, Zonzini L, Montanari D, Melotto S, Gerrard PA, Trist DG, Ratti E, Corsi M: Discovery and biological characterization of (2R,4S)-1'-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2- methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate. J Med Chem. 2011 Feb 24;54(4):1071-9. doi: 10.1021/jm1013264. Epub 2011 Jan 13.
GroupsInvestigational
Direct ClassificationPhenylpiperazines
SMILESC[C@@H](N(C)C(=O)N1CCNC[C@@H]1C1=CC=C(F)C=C1C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
Pathways
PharmGKB
ChEMBLCHEMBL522987